A61P 3 - Drugs for disorders of the metabolism

Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2004
12/30/2004	US20040266670 Reduce blood glucose concentration
12/30/2004	US20040265979 Novel macrophage foam cell formation inhibitor fka-25 and process for producing the same
12/30/2004	US20040265968 Tissue plasminogen activator-like protease
12/30/2004	US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
12/30/2004	US20040265807 Enzymes
12/30/2004	US20040265466 Oil composition
12/30/2004	US20040265426 Process for producing miso
12/30/2004	US20040265399 plant extracts used for prevention or treatment of lesions caused by estrogen deficiency
12/30/2004	US20040265382 Methylsulfonylphenyl or phenylsulfonamide derivatives having ring selected from cyclopentenone, furanone, methylpyrazole, isoxazole and pyridine; celecoxib and rofecoxib; administered for pain; oral drug delivery
12/30/2004	US20040265358 Modified methionine rich food products and process for their manufacture
12/30/2004	US20040265357 Combination of liponic acid and glutamine in food and pharmaceutical products
12/30/2004	US20040265299 Comprising dextrin, starch, peach resin and magnesium stearate; use in hyperthyroidism therapy; reduce serum thyroid hormones level by binding thyroid hormones which is excreted to intestinal tract; hormone inhibitors
12/30/2004	US20040261190 Hydrazono-malonitriles
12/30/2004	DE202004017113U1 Momordica charantia-Zimt-Zubereitung Momordica charantia cinnamon Preparation
12/30/2004	DE202004017112U1 Herbal composition especially for use in diet plans for diabetes mellitus contains Momordica charantia (bitter melon) and other plant parts
12/29/2004	WO2004113562A1 Method for assaying lkb1 phosphorylation activity
12/29/2004	WO2004113519A2 Alcohol dehydrogenase sequences useful for developing compounds for the prevention and/or treatment of metabolic diseases
12/29/2004	WO2004113381A1 Relaxin superfamily peptide analogues
12/29/2004	WO2004113367A1 Peptide having apoptosis-inhibiting activity
12/29/2004	WO2004113359A1 Pyrazole derivative, drug composition containing the same and production intermediate therefor
12/29/2004	WO2004113345A1 Fused pyrrole compound and medicinal use thereof
12/29/2004	WO2004113336A1 Carboline and betacarboline derivatives for use as hdac enzyme inhibitors
12/29/2004	WO2004113331A1 Novel compounds that modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions
12/29/2004	WO2004113310A1 Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing
12/29/2004	WO2004113300A1 Novel tricyclic heterocycle compound
12/29/2004	WO2004113292A2 Fluvastatin sodium crystal forms, processes for preparing them, compositions containing them and methods of using them
12/29/2004	WO2004113291A2 Fluvastatin sodium crystal forms xiv, lxxiii,lxxix, lxxx and lxxxvii, processes for preparing them, compositions containing them and methods of using them
12/29/2004	WO2004113289A2 Glycosidase inhibitors and methods of synthesizing same
12/29/2004	WO2004113276A1 2-ethoxy-3-phenylpropionic acid derivatives for the treatment of lipid disorders
12/29/2004	WO2004113270A2 Propionic acid derivatives useful in the treatment of lipid disorders
12/29/2004	WO2004113266A1 Derivatives of phenylalkyl and phenoxyalkyl acids for the treatment of the hyperglycaemia and hypertriglyceridaemia and type 2 diabetes and process for preparing them
12/29/2004	WO2004112817A1 Extract from plant of japanese parsley family and process for producing the same
12/29/2004	WO2004112793A1 Guanidino-substituted quinazolinone compounds as mc4-r agonists
12/29/2004	WO2004112789A1 Ophthalmic composition
12/29/2004	WO2004112788A1 Pyridoxamine for the treatment of diabetic kidney disease
12/29/2004	WO2004112766A1 Composition for lowering blood glucose
12/29/2004	WO2004112762A2 Pharmaceutical formulations of amyloid inhibiting compounds
12/29/2004	WO2004112701A2 Cyclohexylglycine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/29/2004	WO2004112510A1 Movement physiology improver
12/29/2004	WO2004092146A3 N- (((((1,3-thiazol-2-yl) amino) carbonyl) phenyl) sulfonyl) phenylalanine derivatives and related compounds for the treatment of diabetes
12/29/2004	WO2004089964A8 Lipid-regulating agent and use thereof
12/29/2004	WO2004076657A3 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides
12/29/2004	WO2004075815A3 Diarylcycloalkyl derivatives, method for their production and their use as medicaments
12/29/2004	WO2004048419A9 Method of classifying, purifying and using fenugreek seeds
12/29/2004	WO2004009091A8 Purine derivatives as liver x receptor agonists
12/29/2004	WO2003045984A3 Fibronectin and fibrinogen biopolymer markers indicative of insulin resistance
12/29/2004	WO2003045392A8 Use of n-(indolcarbonyl-)piperazine derivatives
12/29/2004	WO2003015797A8 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine
12/29/2004	WO2002043648A3 Compounds active at the glucocorticoid receptor ii
12/29/2004	WO2000061774A3 Bone morphogenic proteins
12/29/2004	EP1491556A1 Humanized immunoglobulins and their production and use
12/29/2004	EP1491541A1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1491540A1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1491200A1 Use of pyridoxal phosphate derivatives for the treatment of diabetes and related complications
12/29/2004	EP1491196A2 Method for treatment of CNS-involved lysosomal storage diseases
12/29/2004	EP1491194A1 Vdac regulator
12/29/2004	EP1491193A1 Therapeutic combinations comprising amlodipine and atorvastatin
12/29/2004	EP1491192A1 Biological activity-promoting compositions containing soybean germ-origin isoflavone aglycon
12/29/2004	EP1491187A1 Preventive or therapeutic agent for kidney disease
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490519A2 Life sciences business systems and methods
12/29/2004	EP1490474A2 Method for producing pseudo islets
12/29/2004	EP1490406A1 Costimulatory molecule and its use
12/29/2004	EP1490405A2 ANTAGONISTIC ANTI-hFAS LIGAND HUMAN ANTIBODIES AND FRAGMENTS THEREOF
12/29/2004	EP1490365A1 Azaindoles as inhibitors of c-jun n-terminal kinases
12/29/2004	EP1490364A1 7-azaindoles as inhibitors of c-jun n-terminal kinases for the treatment of neurodegenerative disorders
12/29/2004	EP1490361A1 Polycyclic compounds as potent alpha2-adrenoceptor antagonists
12/29/2004	EP1490360A1 Thiazolidinedione derivatives and pharmaceutical composition comprising the same
12/29/2004	EP1490356A1 (3z)-3-(3-hydro-isobenzofuran-1-ylidene)-1,3-dihydro-2h-indol-2-ones as kinase inhibitors
12/29/2004	EP1490355A1 Indolylmaleimide derivatives
12/29/2004	EP1490343A1 New aryl imidazoles and related compounds as c5a receptor modulators
12/29/2004	EP1490341A1 Novel adamantane derivatives
12/29/2004	EP1490339A1 Novel chalcone derivatives and uses thereof
12/29/2004	EP1490335A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/29/2004	EP1490333A1 New atorvastatin salts and pharmaceutical compositions containing them
12/29/2004	EP1490317A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490315A1 Controlling chemical reactions by spectral chemistry and spectral conditioning
12/29/2004	EP1490080A1 A process for the extraction of anthocyanins from black rice and composition thereof
12/29/2004	EP1490072A1 Novel therapeutical use of agonist ligands specific to g2a receptor
12/29/2004	EP1490070A2 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy
12/29/2004	EP1490069A2 Alpha aed and beta aed regulation of nuclear transcription, gene regulation, and/or gene expression
12/29/2004	EP1490065A1 Benzylimidazolyl substituted 2-quinolinone and quinazolinone derivatives for use as farnesyl transferase inhibitors
12/29/2004	EP1490064A1 Substituted pyridinones as modulators of p38 map kinase
12/29/2004	EP1490062A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
12/29/2004	EP1490060A1 Antidiabetic agents
12/29/2004	EP1490059A1 Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
12/29/2004	EP1490058A1 Peroxisome proliferator activated receptor modulators
12/29/2004	EP1490050A2 Methods for alzheimer's disease treatment and cognitive enhancement
12/29/2004	EP1490047A2 Certain pharmaceutically useful substituted aminoalkyl heterocycles
12/29/2004	EP1490044A1 Combination therapy for the treatment of conditions with pathogenic inflammatory components
12/29/2004	EP1490043A2 Spirocyclic amides as cannabinoid receptor modulators
12/29/2004	EP1439818B1 Chewable tablet containing lysine
12/29/2004	EP1379140A4 Production of pancreatic islet cells and delivery of insulin
12/29/2004	EP1373259B1 Pyridazinone aldose reductase inhibitors
12/29/2004	EP1368046B1 Pharmaceutical formulation and the use thereof for preparing a medicament for the treatment of cardiovascular diseases
12/29/2004	EP1334094B1 Cholesterol lowering benzo[b]thiophenes and benzo[d]isothiazoles
12/29/2004	EP1289931B1 Double salts of fumaric acid with a carnitine and an amino acid and food supplements, dietary supplements and drugs containing same
12/29/2004	EP1282612B1 Alkynyl phenyl heteroaromatic glucokinase activators
12/29/2004	EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment
12/29/2004	EP1265891B1 Novel lipoic acid heterocyclic or benzene derivatives, preparation and use thereof as medicines

1 ... 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 ... 1298